Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil

Nutrition and Cancer

Volumn 67, Issue 8, 2015, Pages 1295-1306

  Pandey, Arvind ^a,b   Vishnoi, Kanchan ^a   Mahata, Sutapa ^a   Tripathi, Satyendra Chandra ^d   Misra, Sri Prakash ^c   Misra, Vatsala ^c   Mehrotra, Ravi ^a   Dwivedi, Manisha ^c   Bharti, Alok C ^a,e  

^a INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^b UNIVERSITY OF ALLAHABAD   (India)

^c MLN MEDICAL COLLEGE   (India)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CASPASE 3; CASPASE 9; CURCUMIN; FLUOROURACIL; QUERCETIN; STAT3 PROTEIN; SURVIVIN; BIRC5 PROTEIN, HUMAN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; STAT3 PROTEIN, HUMAN;

ARTICLE; CANCER RESISTANCE; CELL DEATH; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DOWN REGULATION; DRUG ACTIVITY; DRUG MEGADOSE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; LOW DRUG DOSE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STOMACH CANCER; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DRUG EFFECTS; DRUG POTENTIATION; DRUG RESISTANCE; HUMAN; METABOLISM; STOMACH NEOPLASMS; TUMOR CELL LINE;

BERBERINE; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DNA; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FLUOROURACIL; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NF-KAPPA B; QUERCETIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS;

EID: 84948718867     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1085581     Document Type: Article

References (44)

1. IARC. Globocan 2012. Geneva, Switzerland: World Health Organization, 2013. Retreived from http://globocan.iarc.fr/Default. Aspx.
2. Garrido M, Fonseca PJ, Vieitez JM, Frunza M, and Lacave AJ: Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer. Expert Rev Anticancer Ther 14, 887-900, 2014. doi:10.1586/14737140.2014.915194
3. Ikeguchi M, Liu J, and Kaibara N: Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment. Apoptosis 7, 23-29, 2002.
4. Fulda S, and Debatin KM: Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 23, 6702-6711, 2004. doi:10.1038/sj.onc.1207630
5. Wang L, Zhang GM, and Feng ZH: Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line. Acta Pharmacol Sin 24, 1235-1240, 2003.
6. Altieri DC: New wirings in the survivin networks. Oncogene 27, 6276-6284, 2008. doi:10.1038/onc.2008.303
7. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, et al.: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584, 1998. doi:10.1038/25141
8. Altieri DC: Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8, 61-70, 2008. doi:10.1038/nrc2293
9. Scheper MA, Nikitakis NG, Sauk JJ: Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer. Int J Oral Maxillofac Surg 36, 632-639, 2007. doi:10.1016/j. ijom.2007.04.003
10. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, et al.: Stat3 as an oncogene. Cell 98, 295-303, 1999.
11. Woo S, Lee BL, Yoon J, Cho SJ, Baik TK, et al.: Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1alpha in human gastric cancer. Pathobiology 78, 295-301, 2011. doi:10.1159/000321696
12. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, et al.: STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 23, 4921-4929, 2004. doi:10.1038/sj.onc.1207606
13. Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, et al.: Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 103, 3175-3184, 2004.
14. Boehm AL, Sen M, Seethala R, Gooding WE, Freilino M, et al.: Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neck. Mol Pharmacol 73, 1632-1642, 2008.
15. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, et al.: Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 12, 11-19, 2006. doi: 10.1158/1078-0432.CCR-04-1752 [doi]
16. Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, et al.: Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 21, 7611-7618, 2002
17. Li QX, Zhao J, Liu JY, Jia LT, Huang HY, et al.: Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers. Cancer Biol Ther 5, 860-866, 2006. doi:2893 [pii]
18. Yonesaka K, Tamura K, Kurata T, Satoh T, Ikeda M, et al.: Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin. Int J Cancer 118, 812-820, 2006. doi:10.1002/ijc.21350
19. Na YS, Yang SJ, Kim SM, Jung KA, Moon JH, et al.: YM155 induces EGFR suppression in pancreatic cancer cells. PLoS One 7, e38625, 2012. doi:10.1371/journal.pone.0038625
20. Diogo CV, Machado NG, Barbosa IA, Serafim TL, Burgeiro A, et al.: Berberine as a promising safe anti-cancer agent: is there a role for mitochondria? Curr Drug Targets 12, 850-859, 2011.
21. Gupta SC, Kismali G, and Aggarwal BB: Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 39, 2-13, 2013. doi:10.1002/biof.1079
22. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, et al.: A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 45, 2179-2205, 2007. doi:10.1016/j.fct.2007.05.015
23. Bharti AC, Donato N, and Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171, 3863-3871, 2003
24. Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, et al.: Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer 10, 39, 2011. doi:10.1186/1476-4598-10-39
25. Chen W, Wang X, Zhuang J, Zhang L, and Lin Y: Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis 28, 2114-2121, 2007. doi:10.1093/carcin/bgm133
26. Youn MJ, So HS, Cho HJ, Kim HJ, Kim Y, et al.: Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells. Biol Pharm Bull 31, 789-795, 2008
27. Michaud-Levesque J, Bousquet-Gagnon N, Beliveau R: Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp Cell Res 318, 925-935, 2012. doi:10.1016/j. yexcr.2012.02.017
28. Mahata S, Maru S, Shukla S, Pandey A, Mugesh G, et al.: Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells. BMC Complement Altern Med 12, 15, 2012. doi:10.1186/1472-6882-12-15
29. Shukla S, Shishodia G, Mahata S, Hedau S, Pandey A, et al.: Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Mol Cancer 9, 282, 2010. doi: 10.1186/1476-4598-9-282
30. Shukla S, Mahata S, Shishodia G, Pandey A, Tyagi A, et al.: Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. PLoS One 8, e67849, 2013. doi:10.1371/journal.pone.0067849
31. Virrey JJ, Guan S, Li W, Schonthal AH, Chen TC, et al.: Increased survivin expression confers chemoresistance to tumor-associated endothelial cells. Am J Pathol 173, 575-585, 2008. doi:10.2353/ajpath.2008.071079
32. Brenes O, Arce F, Gatjens-Boniche O, Diaz C: Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Biomed Pharmacother 61, 347-355, 2007. doi:10.1016/j. biopha.2007.02.007
33. Al-Joud FS, Alias IZ, and Samsudin AR: The effects of chemotherapeutic drugs on viability, apoptosis, and survivin expression in MCF-7 cells. Acta Histochemica et Cytochemica 38, 323-330, 2005
34. Lu YH, Wang K, He R, and Xi T: Knockdown of survivin and upregulation of p53 gene expression by small interfering RNA induces apoptosis in human gastric carcinoma cell line SGC-823. Cancer Biother Radiopharm 23, 727-734, 2008. doi:10.1089/cbr.2008.0503
35. Miao GY, Lu QM, and Zhang XL: Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells. World J Gastroenterol 13, 1170-1174, 2007.
36. Nakahara T, Kita A, Yamanaka K, Mori M, Amino N, et al.: YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res 67, 8014-8021, 2007. doi:10.1158/0008-5472. CAN-07-1343
37. Satoh T, Okamoto I, Miyazaki M, Morinaga R, Tsuya A, et al.: Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors. Clin Cancer Res 15, 3872-3880, 2009. doi:10.1158/1078-0432.CCR-08-1946
38. Tolcher AW, Mita A, Lewis LD, Garrett CR, Till E, et al.: Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin. J Clin Oncol 26, 5198-5203, 2008. doi:10.1200/JCO.2008.17.2064
39. Koo JY, Kim HJ, Jung KO, and Park KY: Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. JMedFood 7, 117-121, 2004. doi: 10.1089/1096620041224229
40. Wang Z, Guo X, Liu Z, Cui M, Song F, et al.: Studies on alkaloids binding to GC-rich human survivin promoter DNA using positive and negative ion electrospray ionization mass spectrometry. J Mass Spectrom 43, 327-335, 2008. doi:10.1002/jms.1320
41. Lin S, Gu H, Xu M, Cui X, Zhang Y, et al.: The formation and stabilization of a novel G-quadruplex in the 50-flanking region of the relaxin gene. PLoS One 7, e31201, 2012. doi:10.1371/journal.pone.0031201
42. Shakibaei M, Mobasheri A, Lueders C, Busch F, Shayan P, et al.: Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-kappaB and Src protein kinase signaling pathways. PLoS One 8, e57218, 2013. doi:10.1371/journal.pone.0057218
43. Fulda S, and Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811, 2006. doi:10.1038/sj.onc.1209608
44. Guicciardi ME, and Gores GJ: Unshackling caspase-7 for cancer therapy. J Clin Invest 123, 3706-3708, 2013. doi:10.1172/JCI71440